Study of Verinurad in Heart Failure With Preserved Ejection Fraction
Public ClinicalTrials.gov record NCT04327024. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicentre, Double-Blind, Placebo and Active Control Efficacy and Safety Study to Evaluate Verinurad Combined With Allopurinol in Heart Failure With Preserved Ejection Fraction
Study identification
- NCT ID
- NCT04327024
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 159 participants
Conditions and interventions
Interventions
- Verinurad Drug
- Allopurinol Drug
- Placebo for verinurad Drug
- Placebo for allopurinol Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 18, 2020
- Primary completion
- Apr 28, 2022
- Completion
- Apr 28, 2022
- Last update posted
- Jun 28, 2023
2020 – 2022
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Granada Hills | California | 91344 | — |
| Research Site | Northridge | California | 91324 | — |
| Research Site | Torrance | California | 90502 | — |
| Research Site | Miami | Florida | 33135 | — |
| Research Site | Pembroke Pines | Florida | 33024 | — |
| Research Site | Port Orange | Florida | 32127 | — |
| Research Site | Winston-Salem | North Carolina | 27157 | — |
| Research Site | Norfolk | Virginia | 23510 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04327024, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 28, 2023 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04327024 live on ClinicalTrials.gov.